Published in Onco Targets Ther on March 05, 2015
Global cancer statistics. CA Cancer J Clin (2011) 185.92
The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53. Cell (1990) 20.60
EUROCARE-4. Survival of cancer patients diagnosed in 1995-1999. Results and commentary. Eur J Cancer (2009) 5.61
PI3K pathway regulates survival of cancer stem cells residing in the perivascular niche following radiation in medulloblastoma in vivo. Genes Dev (2008) 3.50
The role of PTEN/Akt/PI3K signaling in the maintenance and viability of prostate cancer stem-like cell populations. Proc Natl Acad Sci U S A (2008) 3.13
Cancer trends in China. Jpn J Clin Oncol (2010) 3.06
The role of PI3K/AKT, MAPK/ERK and NFkappabeta signalling in the maintenance of human embryonic stem cell pluripotency and viability highlighted by transcriptional profiling and functional analysis. Hum Mol Genet (2006) 2.41
Brain cancer stem cells display preferential sensitivity to Akt inhibition. Stem Cells (2008) 2.12
HPV infections and oesophageal cancer. J Clin Pathol (2002) 1.97
CD44 expression predicts local recurrence after radiotherapy in larynx cancer. Clin Cancer Res (2010) 1.97
Radiation response in two HPV-infected head-and-neck cancer cell lines in comparison to a non-HPV-infected cell line and relationship to signaling through AKT. Int J Radiat Oncol Biol Phys (2009) 1.83
Neurotrophin receptor p75(NTR) characterizes human esophageal keratinocyte stem cells in vitro. Oncogene (2003) 1.30
Nerve growth factor overexpression and autocrine loop in breast cancer cells. Oncogene (2003) 1.25
Tumour stem cell-targeted treatment: elimination or differentiation. Ann Oncol (2006) 1.25
High human papillomavirus oncogene mRNA expression and not viral DNA load is associated with poor prognosis in cervical cancer patients. Clin Cancer Res (2007) 1.12
Identification of candidate murine esophageal stem cells using a combination of cell kinetic studies and cell surface markers. Stem Cells (2006) 1.11
Human papillomavirus in high- and low-risk areas of oesophageal squamous cell carcinoma in China. Br J Cancer (2007) 1.07
Altered expression and activation of the nerve growth factor receptors TrkA and p75 provide the first evidence of tumor progression to effusion in breast carcinoma. Breast Cancer Res Treat (2004) 1.01
The biological role of the low-affinity p75 neurotrophin receptor in esophageal squamous cell carcinoma. Clin Cancer Res (2006) 1.00
Human papillomavirus infection and esophageal squamous cell carcinoma: a case-control study. Cancer Epidemiol Biomarkers Prev (2012) 0.98
Detection of human papillomavirus DNA and p53 gene mutations in esophageal cancer samples and adjacent normal mucosa. Digestion (2001) 0.97
The radiosensitization effect of NS398 on esophageal cancer stem cell-like radioresistant cells. Dis Esophagus (2010) 0.92
Prevalence of human papillomavirus (HPV) in oesophageal squamous cell carcinoma in relation to anatomical site of the tumour. PLoS One (2012) 0.90
E6/E7 oncogenes increase and tumor suppressors decrease the proportion of self-renewing neural progenitor cells. Oncogene (2006) 0.89
Versatile inhibitory effects of the flavonoid-derived PI3K/Akt inhibitor, LY294002, on ATP-binding cassette transporters that characterize stem cells. Clin Transl Med (2012) 0.89
Cyclooxygenase-2 inhibitor NS398 enhances radiosensitivity of radioresistant esophageal cancer cells by inhibiting AKT activation and inducing apoptosis. Cancer Invest (2010) 0.88
p14ARF, a prognostic predictor in HPV-negative vulvar carcinoma. Am J Clin Pathol (2006) 0.87
Human papilloma virus (HPV) antigens in lesions of laryngeal squamous cell carcinomas. ORL J Otorhinolaryngol Relat Spec (1982) 0.84
Anti-HPV-E7 seropositivity and risk of esophageal squamous cell carcinoma in a high-risk population in China. Carcinogenesis (2013) 0.81
Possible role of human papilloma virus infection in response to neoadjuvant therapy in patients with esophageal cancer. Hepatogastroenterology (2008) 0.80